Autopsy report · NCT04004000

Evaluation of Safety, Tolerability, and Changes in Biomarker and Clinical Outcome Assessments of Losmapimod for FSHD1 With Extension

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.

“Sponsor Decision”

The sponsor’s own words in the registry.

Life of this trial

Registered 2 months before it started.
Ran for about 5 years 2 months before it stopped.
14 participants enrolled.
Results were posted on the registry 1 year 1 month after it ended.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: Fulcrum Therapeutics
Sponsor type: Industry
Conditions: Facioscapulohumeral Muscular Dystrophy 1
Interventions: Losmapimod
Participants: 14
Sites: 1
Countries: Netherlands

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.